ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Invesco Nasdaq Biotechnology ETF
34.72
-0.4108
-1.17%
成交量:
7,319
成交額:
25.47萬
市值:
9,650.77萬
市盈率:
- -
高:
35.13
開:
35.13
低:
34.72
收:
35.13
52周最高:
36.84
52周最低:
23.42
股本:
278.00萬
流通股本:
278.00萬
量比:
0.85
換手率:
0.26%
股息:
0.26
股息率:
0.74%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
藥捷安康-B(02617.HK):替恩戈替尼聯合新型內分泌治療用於經治後進展的轉移性去勢抵抗性前列腺癌中國II期臨床試驗完成首例患者給藥
智通财经
·
5小時前
藥捷安康-B(02617):替恩戈替尼聯合新型內分泌治療用於經治後進展的轉移性去勢抵抗性前列腺癌中國II期臨床試驗完成首例患者給藥
智通财经
·
5小時前
開源證券:原料藥板塊業績增速企穩回升 創新藥及CDMO轉型公司進入兑現期
智通财经
·
6小時前
朱保國卸任、公司業績下滑,39歲劉大平能否改變麗珠困局?
市场资讯
·
6小時前
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IBBQ"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.715,"timestamp":1789746594960,"preClose":35.1258,"halted":0,"volume":7319,"delay":0,"changeRate":-0.011695107300047108,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"交易中","change":-0.4108,"latestTime":"09-18 11:59:37 EDT","open":35.13,"high":35.13,"low":34.715,"amount":254655.01711,"amplitude":0.011815,"askPrice":34.74,"askSize":3200,"bidPrice":34.7,"bidSize":800,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":35.1258,"sharesOutstanding":2520001,"nav":34.34966,"aum":95492089.14966,"dividendRate":0.0074,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.14,"preClose":35.1258,"latestTime":"19:58 EDT","volume":117,"amount":4061.8054,"timestamp":1789689522745,"change":0.0142,"changeRate":0.000404,"amplitude":0},"volumeRatio":0.85075,"impliedVol":0.1125,"impliedVolPercentile":0.4821},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.85075,"shares":2780001,"dividePrice":0.2569,"high":35.13,"amplitude":0.011815,"preClose":35.1258,"low":34.715,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.715,"committee":-0.6,"eps":0,"divideRate":0.0074,"volume":7319,"delay":0,"ttmEps":0,"open":35.13,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.472,"twentyDayClose":35.8,"sixtyDayClose":31.2119},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668940687","title":"藥捷安康-B(02617.HK):替恩戈替尼聯合新型內分泌治療用於經治後進展的轉移性去勢抵抗性前列腺癌中國II期臨床試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940687","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668940687?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:54","pubTimestamp":1789728877,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MDTX","PSYK","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668894069","title":"藥捷安康-B(02617):替恩戈替尼聯合新型內分泌治療用於經治後進展的轉移性去勢抵抗性前列腺癌中國II期臨床試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2668894069","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668894069?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 18:54","pubTimestamp":1789728877,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药捷安康-B 发布公告,本公司核心产品替恩戈替尼联合新型内分泌治疗用于经治后进展的转移性去势抵抗性前列腺癌中国II期临床试验,于近日完成首例患者给药。其中新型内分泌治疗药物虽可显著延长患者生存期,为当前mCRPC一线核心治疗方案,但绝大多数患者最终会发生获得性耐药。替恩戈替尼单一疗法已在既往接受过多线治疗的mCRPC患者显出令人鼓舞的抗肿瘤疗效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PSYK","IBBJ","MDTX","02617","BK1161","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668965944","title":"開源證券:原料藥板塊業績增速企穩回升 創新藥及CDMO轉型公司進入兑現期","url":"https://stock-news.laohu8.com/highlight/detail?id=2668965944","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668965944?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 17:28","pubTimestamp":1789723709,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,开源证券发布研报称,国内原料药行业逐渐企稳回升,部分公司积极布局创新药赛道,持续拓展公司天花板,有望进入收获期。开源证券主要观点如下:原料药板块:业绩增速企稳回升,创新药及CDMO转型公司进入兑现期随着原料药行业去库存逐步完成、落后产能加速出清,板块基本面开始出现改善迹象,营收及净利润已逐步触底回升,毛利率相对稳定,估值水平呈现修复趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","BK1574","BK4139","159992","BK1161","06978","CDMO","LNGR","MEDX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668417979","title":"朱保國卸任、公司業績下滑,39歲劉大平能否改變麗珠困局?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668417979","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668417979?lang=zh_tw&edition=fundamental","pubTime":"2026-09-18 17:08","pubTimestamp":1789722480,"startTime":"0","endTime":"0","summary":"朱保国辞任董事长后,丽珠集团总裁39岁的刘大平被推举为新任董事长,接过这家老牌医药企业的掌舵权。2026年9月11日,朱保国宣布退休,一同辞去了丽珠集团以及健康元董事长在内的所有职务。接替朱保国担任丽珠集团董事长的是公司总裁39岁的刘大平。分季度来看,丽珠集团业绩下行压力在第二季度进一步放大,第二季度,公司营收同比下降31.14%,归母净利润同比下降44.86%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-09-18/doc-inisfyex3432880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MEDX","IBBQ","BK1161","BK1574","LNGR","06978"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":55,"pageCount":1,"totalSize":219,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBBQ\",params:#limit:6,delay:false,,,undefined,":[]}}